Prevalence of Spontaneous Clearance of Hepatitis C Virus Infection Doubled From 1998 to 2017.
Autor: | Seo S; Kaiser Permanente Antioch Medical Center, Antioch, California; Kaiser Permanente Walnut Creek Medical Center, Walnut Creek, California. Electronic address: suk.i.seo@kp.org., Silverberg MJ; Division of Research, Kaiser Permanente Northern California, Oakland, California., Hurley LB; Division of Research, Kaiser Permanente Northern California, Oakland, California., Ready J; Kaiser Permanente Santa Clara Medical Center, Santa Clara, California., Saxena V; Kaiser Permanente South San Francisco Medical Center, South San Francisco, California., Witt D; Kaiser Permanente San Rafael Medical Center, San Rafael, California., Hare CB; Kaiser Permanente San Francisco Medical Center, San Francisco, California., Champsi JH; Kaiser Permanente South San Francisco Medical Center, South San Francisco, California., Korn DG; Kaiser Permanente Oakland Medical Center, Oakland, California., Pauly MP; Kaiser Permanente Sacramento Medical Center, Sacramento, California., Chamberland S; Kaiser Permanente Northern California, Regional Pharmacy, Oakland, California., Lai JB; Kaiser Permanente San Rafael Medical Center, San Rafael, California., Marcus JL; Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts. |
---|---|
Jazyk: | angličtina |
Zdroj: | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2020 Feb; Vol. 18 (2), pp. 511-513. Date of Electronic Publication: 2019 Apr 19. |
DOI: | 10.1016/j.cgh.2019.04.035 |
Abstrakt: | Strategic planning for hepatitis C virus (HCV) screening and treatment requires up-to-date information on the prevalence of HCV spontaneous clearance. Published estimates of HCV spontaneous clearance range from 15% to 60%. 1-3 We conducted an observational study over 20 years to evaluate trends in the prevalence of HCV spontaneous clearance. Our goals were to estimate the proportion of HCV-antibody-positive patients who were viremic, and to identify factors associated with viremia, thus facilitating prediction of the number of patients needing treatment. (Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |